丁香通
丁香园
论坛
医药招聘
丁香医生
更多
调查派
用药助手
丁香搜索
医药数据库
来问医生
我要登录
|
免费注册
|
我的丁香通
企业机构:
成为企业机构
个人用户:
个人中心
移动端
搜文献
大家都在搜
大家都在搜
0 人通过求购买到了急需的产品
免费发布求购
搜索
发布求购
全部产品分类
首页
试用中心
实验专区
文献找产品
最新资讯
品牌活动
企业库
品牌库
首页
>
CiteLab
>
Blood Advances
Blood Advances
简称
Blood Adv
大类
医学
小类
血液学
ISSN
2473-9529
EISSN
2473-9537
最新文献
A pilot randomized clinical trial of a peer support intervention for hematopoietic stem cell transplantation
PMID: 41945755
2026-06-09
Transthyretin V122I variant and protein affect cardiac severity and mortality in sickle cell disease
PMID: 41921073
2026-06-09
Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma
PMID: 41886633
2026-06-09
MSLN expression predicts a high risk of EMD in AML by promoting cell adhesion and metastasis via interaction with MUC16
PMID: 41824794
2026-06-09
Effectiveness of health care transition interventions for sickle cell disease
PMID: 41632694
2026-06-09
Targeted LNP-mediated delivery of VE-cadherin mRNA reduces vascular hyperpermeability in vivo
PMID: 41824787
2026-06-09
Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction
PMID: 41875235
2026-06-09
Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy
PMID: 41941698
2026-06-09
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformation
PMID: 41886642
2026-06-09
Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma
PMID: 41824782
2026-06-09
Impact of novel therapies on the efficacy of posttransplantation brentuximab vedotin maintenance in Hodgkin lymphoma
PMID: 41894690
2026-06-09
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantation
PMID: 41860374
2026-06-09
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia
PMID: 41915892
2026-06-09
Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM
PMID: 41894689
2026-06-09
Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study
PMID: 41747197
2026-06-09
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy
PMID: 41855504
2026-06-09
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma
PMID: 41894687
2026-06-09
FDG-PET medullary total tumor volume highlights high-risk patients with newly diagnosed multiple myeloma in CASSIOPEIA trial
PMID: 41894685
2026-06-09
Novel use of a hash-based tokenization for sharing sickle cell disease data without sharing protected health information
PMID: 41860383
2026-05-12
Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice
PMID: 41538305
2026-05-12
上一页
1
2
3
4
5
•••
119
下一页